Found 7 matching trials
A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer PHASE1 This is an international, multisite, open-label, Phase 1b/2 study, to confi...
Show More Location
Site 38 - Northwestern University, Feinberg School of Medicine, Northwestern University
Learn More & Join Trial
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer PHASE1 The purpose of this study is to evaluate the safety and efficacy of samurac...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies PHASE1 This is a modular, Phase I/II, multicentre study to investigate CT7001 mono...
Show More Learn More & Join Trial
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C) PHASE1 The purpose of this study is to learn about the safety and effects of the s...
Show More Status
Active Not Recruiting
Location
Highlands Oncology Group
Learn More & Join Trial
Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer PHASE1 The purpose of this study is to find the highest dose of a drug, samuracicl...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer PHASE1 This is a Phase Ib/II, open-label, multicenter, randomized umbrella study i...
Show More Learn More & Join Trial
A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants PHASE2 The purpose of this study is to evaluate the safety and efficacy of samurac...
Show More Location
Ocala Oncology Center PL DBA Florida Cancer Affiliates
Learn More & Join Trial